Novavax secondary stock offering
WebFeb 28, 2024 · GAITHERSBURG, Md., Feb. 28, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced its financial... WebDec 16, 2024 · Novavax (NASDAQ: NVAX) said it’s now looking to raise $65 million in a common stock offering, selling 6.5 million shares for $10 apiece. The company has also …
Novavax secondary stock offering
Did you know?
WebDec 14, 2024 · In connection with the common stock offering, Novavax expects to grant to the underwriters a 30-day option to purchase up to an additional $18.75 million of its … WebJun 2, 2024 · Novavax originally aimed to file for authorization in the first half of last year, but the company struggled with manufacturing issues, which held up its filing. Meanwhile, Novavax's once...
WebThe 12 analysts offering price forecasts for Novavax have a median target of 169.58, with a high estimate of 294.00 and a low estimate of 27.00. The median estimate represents a 4.72 difference... WebDec 10, 2024 · Novavax stock currently trades at $169 - up 48% across the past 12 months - and has touched peaks of $320 this year. Its lowest price has been $121, so remarkably for a company that traded at $3 ...
WebDec 14, 2024 · In connection with the common stock offering, Novavax expects to grant to the underwriters a 30-day option to purchase up to an additional $18.75 million of its common stock at the public... WebDec 28, 2024 · Novavax estimates that the net proceeds from the Common Stock Offering are approximately $69.8 million, after deducting the underwriters' discounts and commissions and estimated offering expenses.
WebApr 10, 2024 · Novavax ( NASDAQ:NVAX - Get Rating) last announced its quarterly earnings results on Tuesday, February 28th. The biopharmaceutical company reported ($2.28) EPS for the quarter, missing the consensus estimate of ($0.92) by ($1.36). The business had revenue of $357.40 million for the quarter, compared to analysts' expectations of $383.14 …
WebJun 15, 2024 · (Reuters) - Novavax Inc said on Monday it would raise fresh capital through a $200 million preferred stock offering as it races to develop a vaccine for the new … chitin is an example of a quizletWebApr 12, 2024 · Novavax, Inc. has a 12-month low of $5.61 and a 12-month high of $76.77. The firm has a market capitalization of $778.98 million, a P/E ratio of -1.08 and a beta of 1.73. The stock's fifty day simple moving average is $8.11 and its 200-day simple moving average is $13.33. Novavax ( NASDAQ:NVAX - Get Rating) last posted its quarterly … grasmachines lokerenWebNovavax Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NVAX stock price. Dow Jones, a News Corp company About WSJ grasmachines hondaWeb「英単語解説」stock-of-recordの意味について stock-of-recordは 【特定の日に特定の会社の株を所有するすべての人や組織】の意味として使われています。 和訳：【レコードの在庫】 詳細はこちらへアクセスしてください… grasmachines met accuWebJun 14, 2024 · Stock Market Sectors Stock Market Indexes S&P 500 Dow Jones Nasdaq Composite Stock Market angle-down Premium Services Stock Advisor Our Flagship Service Return 395% S&P Return 115% Rule... grasmachine snapperWebFeb 6, 2024 · The Novavax COVID-19 vaccine is the fourth COVID-19 vaccine to be authorized for use in the U.S. It’s given as a two-dose primary series, 3 weeks apart. People ages 12 and older are eligible to receive it. The Novavax COVID-19 vaccine uses more conventional vaccine technology compared to the Pfizer, Moderna, and Johnson & … grasmachines luyckxWebDec 16, 2024 · Concurrently with the offering of the notes, Novavax also announced today the pricing of its previously announced underwritten public offering to sell up to 6,500,000 shares of its common... grasmachines gamma